companies innovating obesity treatment glp-1 drugs 2025 Market Size to Hit USD 132.79 Bn by 2035 What's next for GLP-1 innovation:

Every Wolverine protocol comes from a licensed 503A compounding pharmacy with verified certificates of analysis

In August 2025, Adia Med announced its entry into the USD 1.9 billion glutathione market through the launch of innovative IV glutathione therapies and Glutaryl Transdermal Glutathione Spray

Glutathione injections minimize the damage to the colon for patients with ulcerative colitis

This overlooks the fact that hormonal changes, physical health conditions, or side effects of medications can also shape womens libido

The best hope for BPC is that this new regulatory environment allows for oral versions of the peptide to continue as OTC supplements (no GRAS indication has been given) while injectable forms are prescribed with modifications through compounding pharmacies as PDA or N-acetyl-BPC-157

glutathione-based drips remain the central component of most protocols